Yixin Qi
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Circular RNAs in diseases 4
- Epigenetics and DNA Methylation 3
- RNA modifications and cancer 3
- Oncology 5
- Co-authors
- Jie Hu (4 shared papers)Lijuan Yang (1 shared paper)Sha Zhao (1 shared paper)Baoen Shan (1 shared paper)Quanhai Li (4 shared papers)Hao Ran (4 shared papers)Haoqi Wang (1 shared paper)Fan Zhang (2 shared papers)
- Journals
- Scientific Reports (3 papers)The FASEB Journal (2 papers)Frontiers in Oncology (2 papers)BioMed Research International (1 paper)Frontiers in Nutrition (1 paper)
- Partner nations
- ChinaUnited StatesMalaysia
In The Last Decade
Yixin Qi
32 papers receiving 278 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 60
- Oncology 75
- Immunology 59
- Genetics 23
- Molecular Biology 102
Countries citing papers authored by Yixin Qi
This map shows the geographic impact of Yixin Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yixin Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yixin Qi more than expected).
Fields of papers citing papers by Yixin Qi
This network shows the impact of papers produced by Yixin Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yixin Qi. The network helps show where Yixin Qi may publish in the future.
Co-authors
The 25 scholars most cited alongside Yixin Qi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 69 | |
| 2 | 2021 | 21 | |
| 3 | 2022 | 20 | |
| 4 | 2016 | 20 | |
| 5 | 2019 | 16 | |
| 6 | 2015 | 14 | |
| 7 | 2023 | 13 | |
| 8 | 2023 | 11 | |
| 9 | 2023 | 11 | |
| 10 | 2016 | 11 | |
| 11 | 2022 | 10 | |
| 12 | 2021 | 9 | |
| 13 | 2024 | 6 | |
| 14 | 2024 | 6 | |
| 15 | 2019 | 5 | |
| 16 | 2024 | 4 | |
| 17 | 2021 | 4 | |
| 18 | 2022 | 4 | |
| 19 | 2025 | 3 | |
| 20 | 2024 | 3 |
About Yixin Qi
Yixin Qi is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Epidemiology, having authored 36 papers that have together received 280 indexed citations. Recurring topics across this work include Circular RNAs in diseases (4 papers), Epigenetics and DNA Methylation (3 papers), RNA modifications and cancer (3 papers), Immunotherapy and Immune Responses (2 papers), Psoriasis: Treatment and Pathogenesis (2 papers), Mesenchymal stem cell research (2 papers), Cancer-related molecular mechanisms research (2 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Cancer Research (60 citations), Oncology (75 citations), Immunology (59 citations), Genetics (23 citations) and Molecular Biology (102 citations). Yixin Qi has collaborated with scholars based in China, United States and Malaysia. Frequent co-authors include Jie Hu, Lijuan Yang, Sha Zhao, Baoen Shan, Quanhai Li, Hao Ran, Haoqi Wang, Fan Zhang, Xianyun Wang and Cuizhi Geng. Their work appears in journals such as Scientific Reports, The FASEB Journal, Frontiers in Oncology, BioMed Research International and Frontiers in Nutrition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.